S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
Free Trial

Anavex Life Sciences (AVXL) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free avxl Stock Alerts
$3.64
-0.16 (-4.21%)
(As of 12:38 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 7)
-$0.11 Beat By $0.04
Consensus EPS
(Feb. 7)
-$0.15
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AVXL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVXL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anavex Life Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.15)($0.15)($0.15)
Q2 20241($0.13)($0.13)($0.13)
Q3 20241($0.15)($0.15)($0.15)
Q4 20241($0.18)($0.18)($0.18)
FY 20244($0.61)($0.61)($0.61)

AVXL Earnings Date and Information

Anavex Life Sciences last issued its earnings data on February 7th, 2024. The biotechnology company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $0.04. Anavex Life Sciences has generated ($0.54) earnings per share over the last year (($0.54) diluted earnings per share). Earnings for Anavex Life Sciences are expected to decrease in the coming year, from ($0.57) to ($0.87) per share. Anavex Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Anavex Life Sciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)		------- 
2/7/2024Q1 2024($0.15)($0.11)+$0.04($0.11)--
11/27/2023Q3 2023($0.16)($0.12)+$0.04($0.12)--    
8/8/2023Q3 2023($0.17)($0.14)+$0.03($0.14)--
5/9/2023Q2 2023($0.18)($0.17)+$0.01($0.17)--    
2/7/2023Q1 2023($0.20)($0.17)+$0.03($0.17)--
11/28/2022Q4 2022($0.16)($0.18)($0.02)($0.18)--
8/9/2022Q3 2022($0.15)($0.16)($0.01)($0.16)--    
5/10/2022Q2 2022($0.16)($0.14)+$0.02($0.14)--    
2/9/2022Q1 2022($0.16)($0.14)+$0.02($0.14)--    
11/24/2021Q3 2021($0.15)($0.15)-($0.15)--    
8/11/2021Q2 2021($0.13)($0.14)($0.01)($0.14)--    
5/12/2021Q1 2021($0.12)($0.12)-($0.12)--  

Anavex Life Sciences Earnings - Frequently Asked Questions

When is Anavex Life Sciences's earnings date?

Anavex Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on AVXL's earnings history.

Did Anavex Life Sciences beat their earnings estimates last quarter?

In the previous quarter, Anavex Life Sciences (NASDAQ:AVXL) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.04. Learn more on analysts' earnings estimate vs. AVXL's actual earnings.

How much profit does Anavex Life Sciences generate each year?

Anavex Life Sciences (NASDAQ:AVXL) has a recorded net income of -$47.51 million. AVXL has generated -$0.54 earnings per share over the last four quarters.

What is Anavex Life Sciences's EPS forecast for next year?

Anavex Life Sciences's earnings are expected to decrease from ($0.57) per share to ($0.87) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:AVXL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
My biggest AI fear
Paradigm Press